Patient Characteristics and Treatment History
| Parameter | Data |
| Mean PSA level at presentation (ng/mL) | 46.9 ± 314.7 |
| Mean Gleason score | 6.9 ± 1.5 |
| Interval between initial treatment and PET | |
| <6 mo | 11.8% (30) |
| 6–24 mo | 17.2% (43) |
| >24 mo | 71.0% (177) |
| TNM staging | |
| I | 6.6% (17) |
| II | 51.3% (128) |
| III | 42.1% (105) |
| Treatment | |
| Surgery only | 46.3% (116) |
| Radiotherapy only | 19.1% (48) |
| Both surgery and radiotherapy | 24.0% (60) |
| ADT only | 10.6% (26) |
| Duration of ADT | |
| <6 mo | 18.7% (47) |
| 6–24 mo | 24.5% (61) |
| >24 mo | 56.8% (142) |
Data are mean ± SD, or percentage followed by number of patients in parentheses.